Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Japan flag Japan · Delayed Price · Currency is JPY
5,614.00
-23.00 (-0.41%)
At close: Mar 6, 2026
Market Cap417.34B -2.3%
Revenue (ttm)165.74B +0.1%
Net Income3.66B -63.7%
EPS49.18 -63.7%
Shares Out74.34M
PE Ratio114.15
Forward PE39.78
Dividend106.00 (1.88%)
Ex-Dividend DateDec 29, 2025
Volume180,000
Average Volume233,905
Open5,600.00
Previous Close5,637.00
Day's Range5,559.00 - 5,649.00
52-Week Range4,850.00 - 5,885.00
Beta0.32
RSI51.84
Earnings DateFeb 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g... [Read more]

Founded 1886
Employees 3,615
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Financial Statements